<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="species">mouse</item><item key="factors"><item><item key="GSE14469GSM361386"/></item><item><item key="GSE14469GSM361387"/></item><item><item key="GSE14469GSM361388"/></item><item><item key="GSE14469GSM361389"/></item><item><item key="GSE14469GSM361390"/></item></item><item key="id">5605</item><item key="pop_total">0</item><item key="platform">6</item><item key="summary_wrapped">Synovial sarcoma-like tumors were generated in mice by conditionally expressing the human t(X;18) translocation-derived SYT-SSX2 fusion...</item><item key="geo_gse_id">E-GEOD-14469</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">0</item><item key="sample_count">5</item><item key="tags"><item>protein</item><item>sarcoma</item><item>synovial sarcoma</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">transcription-profiling-of-synovial-sarcoma-like-t</item><item key="geo_id_plat">E-GEOD-14469_A-AFFY-45</item><item key="name">Transcription profiling of synovial sarcoma-like tumors induced in a genetically engineered mouse model</item><item key="created">Nov.10, 2014</item><item key="summary">Synovial sarcoma-like tumors were generated in mice by conditionally expressing the human t(X;18) translocation-derived SYT-SSX2 fusion protein. Using a Tamoxifen-inducible CreER system, we show here that sporadic expression of SYT-SSX2 across multiple tissue types leads to exclusive formation of synovial sarcoma-like tumors while its widespread expression is lethal.  CreER-based sporadic expression both avoids the severe early developmental phenotypes     associated with widespread SYT-SSX2 expression and better models natural pathogenesis of cancers where transformed cells usually arise within an environment of largely normal cells. Experiment Overall Design: Genetically engineered mice capable of conditionally expressing the human synovial sarcoma-associated SYT-SSX2 fusion oncogene were mated with genetically engineered mice expressing the CreER fusion protein from ROSA locus. The progenies harboring both CreER and SYT-SSX2 were followed up with or without tamoxifen injection. Tumors were generated in these mice that were dissected out, RNA extracted, and subjected to expression profiling by microarray analysis.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-14469</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-14469/samples/</item></data></biogps>
